Tetra Pharm Technologies Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
55
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7.26M
- Investors
-
2
Tetra Pharm Technologies General Information
Description
Operator of a biopharmaceutical company intended to deliver cannabinoid-based therapies. The company specializes in the development of pharmaceutical drugs aimed at the central nervous system and the immune system and offers a suite of tailored end-to-end contract development and manufacturing services, enabling healthcare industries to treat neurological diseases and mental health disorders.
Contact Information
Website
www.tetrapharm.euCorporate Office
- Ørestads Boulevard 108
- 2300 Copenhagen
- Denmark
Corporate Office
- Ørestads Boulevard 108
- 2300 Copenhagen
- Denmark
Tetra Pharm Technologies Timeline
Tetra Pharm Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 12-Apr-2024 | $7.26M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 26-Jan-2023 | Completed | Startup | |||
| 2. Early Stage VC | 08-Feb-2022 | $1.53M | $3.81M | Completed | Startup | |
| 1. Seed Round | 15-Dec-2021 | $2.28M | $2.28M | Completed | Startup |
Tetra Pharm Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 2,564 | $570.32 | $570.32 | 1x | $570.32 | 3.79% | ||
| Ordinary | 8,076 | $270.07 | $270.07 | 1x | $270.07 | 11.95% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Tetra Pharm Technologies Patents
Tetra Pharm Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026037496-A1 | A self-emulsifying solid composition comprising a cannabinoid | Pending | 14-Aug-2024 | ||
| WO-2024165166-A1 | A cannabinoid-based o/w emulsification system for oral administration targeting endocannabinoid receptors | Inactive | 10-Feb-2023 | ||
| WO-2024165165-A1 | A cannabinoid-based o/w emulsification system for sublingual and buccal administration targeting endocannabinoid receptors | Inactive | 10-Feb-2023 | ||
| EP-4493154-A1 | A cannabinoid-based oil-in-water emulsion for sublingual and buccal administration | Pending | 10-Feb-2023 | ||
| WO-2024165731-A1 | A cannabinoid-based oil-in-water emulsion for sublingual and buccal administration | Inactive | 10-Feb-2023 | A61K9/1075 |
Tetra Pharm Technologies Signals
Tetra Pharm Technologies Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enexis (Sweden) | Venture Capital | Minority | ||
| Leafy Tunnel | Venture Capital | Minority |
Tetra Pharm Technologies FAQs
-
When was Tetra Pharm Technologies founded?
Tetra Pharm Technologies was founded in 2019.
-
Where is Tetra Pharm Technologies headquartered?
Tetra Pharm Technologies is headquartered in Copenhagen, Denmark.
-
What is the size of Tetra Pharm Technologies?
Tetra Pharm Technologies has 55 total employees.
-
What industry is Tetra Pharm Technologies in?
Tetra Pharm Technologies’s primary industry is Pharmaceuticals.
-
Is Tetra Pharm Technologies a private or public company?
Tetra Pharm Technologies is a Private company.
-
What is the current valuation of Tetra Pharm Technologies?
The current valuation of Tetra Pharm Technologies is .
-
What is Tetra Pharm Technologies’s current revenue?
The current revenue for Tetra Pharm Technologies is .
-
How much funding has Tetra Pharm Technologies raised over time?
Tetra Pharm Technologies has raised $20.5M.
-
Who are Tetra Pharm Technologies’s investors?
Enexis (Sweden) and Leafy Tunnel have invested in Tetra Pharm Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process